Dalfampridine | C5H6N2 | CID 1727 - PubChem
Aminopyridines for the treatment of neurologic disorders. - Abstract - Europe PMC
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis. - Munich Cluster for Systems Neurology - LMU Munich
4-Aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Commentary - Hans-Peter Hartung, Michael Dietrich, Philipp Albrecht, 2020
Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers | Scientific Reports
Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology
4-Aminopyridine Capsules Compounded
Multiple Sclerosis
4-Aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis | Neurology
Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers | Scientific Reports
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis - YouTube
Neuroprotective Properties of 4-Aminopyridine | Neurology Neuroimmunology & Neuroinflammation
Neuroprotective Properties of 4-Aminopyridine | Neurology Neuroimmunology & Neuroinflammation
Structure-activity relationship studies of four novel 4-aminopyridine K+ channel blockers | Scientific Reports
MS Brain | The Relationship Between MS and Your Brain
4-Aminopyridine - Wikipedia
Treatment with an antigen-specific dual microparticle system reverses advanced multiple sclerosis in mice | PNAS
IJMS | Free Full-Text | Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
The Compounder - 4-Aminopyridine
Frontiers | Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
![PDF] 4-aminopyridine – the new old drug for the treatment of neurodegenerative diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dd076ac173ae7cbf451247eac5d9751555162d8d/7-Table1-1.png "PDF] 4-aminopyridine – the new old drug for the treatment of neurodegenerative diseases | Semantic Scholar")
PDF] 4-aminopyridine – the new old drug for the treatment of neurodegenerative diseases | Semantic Scholar
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis - YouTube
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study - The Lancet Neurology
Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine* - Journal of Biological Chemistry
Disease modifying nutricals” for multiple sclerosis - ScienceDirect
AMPYRA (dalfampridine) Extended Release Tablets | Acorda.com
Multiple sclerosis and drug discovery: A work of translation - eBioMedicine
